𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab

✍ Scribed by Jens Chemnitz; Andreas Draube; Volker Diehl; Jürgen Wolf


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
109 KB
Volume
69
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Histopathologic and clinical outcome of
✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn Jónsdóttir; Stefan H. Jacobson; Elisa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose